Epilepsy Foundation Awards Second Round of “Epilepsy Innovation Seals of Excellence” to Accelerate New Therapies for People Living with Seizures
BioCrea GmbH and NeuroGate Therapeutics Each Receive SEAL and $25,000 to Foster Continued DevelopmentLANDOVER, MD, January 7, 2014 – The Epilepsy Foundation, a national organization dedicated to providing services and support to all people living with epilepsy and seizures, has awarded the “Epilepsy Innovation Seal of Excellence” (SEAL) to two companies – BioCrea GmbH and Neurogate Therapeutics – who are taking the lead in developing new treatment options that deserve significant and urgent support. The SEAL is part of the Foundation’s mandate to recognize critical advancements in the